ATLAS fair value
ATLAS has no fair value for this stock today.
Warby Parker stock price today, ATLAS forecast and fair value
Healthcare · Medical Instruments & Supplies · NYSE
Prices as of Oct 27, 2026 · USD
ATLAS has no fair value for this stock today.
47%
that it ends higher than today in 21 sessions
ATLAS's own quantitative analysis, all in one place.
Plans from €3.99 a month.
ATLAS's model gives Warby Parker a 47% chance of finishing higher a month from now (21 trading sessions) than today: close to a coin flip.
In half of the simulated outcomes the price ends between $22.31 and $27.61; in 9 out of 10, between $18.46 and $33.36. Estimated annual volatility is 61%.
ATLAS does not publish a fair value for WRBY right now, but it does show its odds of rising: close to a coin flip.
Over the last 52 weeks WRBY has traded between $14.96 and $31.00. Today it is 19.1% below that high and 68% above its low.
On the business: revenue grew 13.0% year over year; net margin is 0.2%; it trades at 443.5 times earnings.
Its beta is 1.91: it tends to move more than the market, both up and down.
Warby Parker Inc. Class A Common Stock is the equity of Warby Parker, a direct-to-consumer eyewear company that designs, sells, and distributes prescription glasses, sunglasses, contact lenses, and related accessories.
Want to see everything about Warby Parker?
Get started →Plans from €3.99 a month.
Other companies in the same line of business:
Warby Parker Inc. Class A Common Stock is the equity of Warby Parker, a direct-to-consumer eyewear company that designs, sells, and distributes prescription glasses, sunglasses, contact lenses, and related accessories.
47%: close to a coin flip. In half of the simulated outcomes, WRBY ends the month between $22.31 and $27.61.
Warby Parker's market capitalization is $3.4B. Its price-to-earnings (P/E) ratio is 443.5: you pay $443.5 for each $1 of yearly earnings.
ATLAS estimates annual volatility at 61%. In a typical month, half of the outcomes end between $22.31 and $27.61.
Not investment advice. ATLAS estimates are produced by statistical models from public data; they can be wrong and past performance does not predict future results. Consider your own situation before investing. Disclaimer
ATLAS Signals
The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.
By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy